BRNS | NASDAQ

Barinthus Biotherapeutics Plc.

Barinthus Biotherapeutics Plc. (BRNS) | runway 14.0 months | financing risk lower | market cap $24.9M. Daily snapshot of financials, capital pressure, and re...

Company websiteLast updated Apr 29, 2026

Share price

$0.60

As of Apr 29, 2026

Market cap

$24.9M

Snapshot valuation

30D volume

30,649 shares

Rolling average daily volume

Runway

14.0 months

Estimated from precomputed burn and cash

Financing risk

N/A

Current liquidity and recent financing activity do not point to an immediate capital raise.

Snapshot summary

Runway: 14.0 months based on estimated burn.

Financing signal: Current liquidity and recent financing activity do not point to an immediate capital raise.

Latest development: Barinthus Biotherapeutics plc. 8-K 2026-04-22.

Recent developments

Barinthus Biotherapeutics plc. 8-K 2026-04-22

8-K filed on 2026-04-22.

Apr 21, 2026, 8:00 PM

Barinthus Biotherapeutics plc. 8-K 2026-03-31

8-K filed on 2026-03-31.

Mar 30, 2026, 8:00 PM

Barinthus Biotherapeutics plc. 10-K 2026-03-13

10-K filed on 2026-03-13.

Mar 12, 2026, 8:00 PM

Barinthus Biotherapeutics plc. 8-K 2026-03-13

8-K filed on 2026-03-13.

Mar 12, 2026, 8:00 PM

Barinthus Biotherapeutics plc. 8-K 2026-02-23

8-K filed on 2026-02-23.

Feb 22, 2026, 7:00 PM

Premium analysis

Full filing analysis and proprietary signal detail

Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.

Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures